User profiles for "author:Joanna Grogono"
Joanna GrogonoClinical Research Fellow, Oxford Brookes University Verified email at brookes.ac.uk Cited by 620 |
Localization of M2 and M3 Muscarinic Receptors in Human Bladder Disorders and Their Clinical Correlations
G Mukerji, Y Yiangou, J Grogono… - The Journal of …, 2006 - auajournals.org
Purpose: We studied the cellular localization of muscarinic receptor subtypes 2 and 3 in the
human bladder and related any changes in overactive and painful bladder syndromes to …
human bladder and related any changes in overactive and painful bladder syndromes to …
Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia
Objective Cabergoline is a highly effective medical treatment for patients with
hyperprolactinaemia. There is an increased risk of valvular heart disease in patients …
hyperprolactinaemia. There is an increased risk of valvular heart disease in patients …
[HTML][HTML] Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial
JC Grogono, C Butler, H Izadi, SH Moosavi - Respiratory research, 2018 - Springer
Background Inhaled furosemide offers a potentially novel treatment for dyspnoea, which
may reflect modulation of pulmonary stretch receptor feedback to the brain. Specificity of …
may reflect modulation of pulmonary stretch receptor feedback to the brain. Specificity of …
Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary …
J Masters, G Morton, I Anton, J Szymanski… - Open …, 2017 - openheart.bmj.com
Objective The study aimed to evaluate the impact of a multidisciplinary inpatient heart failure
team (HFT) on treatment, hospital readmissions and mortality of patients with …
team (HFT) on treatment, hospital readmissions and mortality of patients with …
An active fixation quadripolar left ventricular lead for cardiac resynchronization therapy with reduced postoperative complication rates
C Robertson, O Duffey, PT Tang… - Journal of …, 2022 - Wiley Online Library
Background The rate of left ventricular (LV) lead displacement after cardiac
resynchronization therapy (CRT) remains high despite improvements in lead technology. In …
resynchronization therapy (CRT) remains high despite improvements in lead technology. In …
Simultaneous myocardial infarction and ischaemic stroke secondary to paradoxical emboli through a patent foramen ovale
Myocardial infarction (MI) and stroke are common acute conditions that regularly present as
an emergency to hospital. Paradoxical embolism is a recognised complication of patent …
an emergency to hospital. Paradoxical embolism is a recognised complication of patent …
Letter by Gamble et al Regarding Article,“Inappropriate Shocks due to Subcutaneous Air in a Patient With a Subcutaneous Cardiac Defibrillator”
JHP Gamble, J Grogono, K Rajappan… - Circulation …, 2014 - Am Heart Assoc
We encountered a similar phenomenon in a recent patient, although in our case it was
because of air entrapment around the proximal sensing electrode. Our patient was a 22-year …
because of air entrapment around the proximal sensing electrode. Our patient was a 22-year …
Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure
C Turnquist, JC Grogono, M Hofer… - … Heart Journal-Case …, 2021 - academic.oup.com
Background Sporadic late-onset nemaline myopathy (SLONM) is a rare, acquired, adult-
onset myopathy, characterized by proximal muscle weakness and the pathognomonic …
onset myopathy, characterized by proximal muscle weakness and the pathognomonic …
[PDF][PDF] Mechanisms and Management of Breathlessness in Chronic Heart Failure
JC Grogono - 2020 - radar.brookes.ac.uk
Background: The pathophysiology of dyspnoea ('breathlessness') is poorly understood and
treatment options limited. This is particularly true for heart failure in which dyspnoea is a …
treatment options limited. This is particularly true for heart failure in which dyspnoea is a …
[CITATION][C] Debating pharmacological options for dyspnoea relief; the need for full, accurate and balanced critical appraisal of the evidence.
JC Grogono, KTS Pattinson, SH Moosavi - Pulmonology, 2019 - europepmc.org
This is a comment on" Strategies to relieve dyspnoea in patients with advanced chronic
respiratory diseases. A narrative review." Pulmonology. 2019 Sep-Oct; 25 (5): 289-298. A …
respiratory diseases. A narrative review." Pulmonology. 2019 Sep-Oct; 25 (5): 289-298. A …